Forte

Forte provides software, consulting, services and managed infrastructure to help cancer centers, AMCs and health systems unleash their research potential.

[Forte @forte]

Tomorrow, we will re-direct the Forte website to Advarra. Follow @advarra on Twitter and LinkedIn for the same great educational resources and product information. https://t.co/Vj3FPzxd4m

[Forte @forte]

Ever wondered if laws similar to the EU General Data Protection Regulation (GDPR) could come to the US? Follow @advarra to stay up to date with our latest blog on the California Consumer Privacy Act’s (CCPA) impact on research. https://t.co/1QiAo2HUpK

[Advarra @advarra]

The California Consumer Privacy Act (CCPA) could end up being the model of #dataprotection in the US. Read our latest blog on the basics of CCPA and its implications on #clinicalresearch. https://t.co/dx9uROtXEG https://t.co/dx9uROtXEG

[Forte @forte]

Integrated research solutions are beneficial to cancer centers in more ways than one — institutions can leverage technology, services, and IRB/IBC to streamline research. https://t.co/E2ofpXrw2h

[Forte @forte]

Clinical Research Coordinators are tasked with many responsibilities throughout the day. Learn more about how to balance each role and responsibility effectively. https://t.co/J2lZdAPcyE

[Forte @forte]

Subject safety and data integrity are paramount to advancing research. How does SDV and SDR impact safe research? https://t.co/Ir77waA2ri

[Forte @forte]

Attending our virtual Onsemble conference this October provides an opportunity to learn and collaborate with industry leaders, moving research forward. https://t.co/zm5LTrjlMF

[Forte @forte]

The COVID-19 pandemic has challenged every aspect of the clinical research industry. This new urgency has affirmed certain clinical trial innovations originally pioneered in the oncology space. https://t.co/lsjCz4g699

[Forte @forte]

Our 2020 Virtual Fall Onsemble Conference is October 6-9. Thinking of attending? Check out these 4 can’t-miss sessions. https://t.co/j7ywJHkmsF

[Forte @forte]

Developing and negotiating a clinical trial budget that applies Medicare’s rules and regulations involves many challenges. Find out strategies to assist with the process. https://t.co/G9KiyA41Ex

[Forte @forte]

Billing compliance is crucial to success in #clinicalresearch, and coverage analysis helps ensure correct billing. Our latest infographic outlines the impact coverage analysis has on billing compliance. https://t.co/m0JCTDMuYq

[Forte @forte]

Since joining forces a year ago, @advarra and Forte have worked to ensure altogether better research, integrating Advarra’s CIRBI platform and Forte eReg. https://t.co/vxmC0rBs9W

[Forte @forte]

Recently, an Advarra/Forte customer utilized the Staff Augmentation Services to assist on a financials roll-out, including centralizing financial services. https://t.co/bG3PduDhoz

[Forte @forte]

When supporting vendor qualification and management programs, there are different audits to consider. This article defines the differences and how to identify vendors with potential risk for your program. https://t.co/CRPDwgl2R5

[Forte @forte]

Protecting participant data is of the utmost importance in clinical research. This article breaks down risk-based monitoring, as well as other data protection terms falling underneath it. https://t.co/fWAGoMzXM2

[Forte @forte]

This year’s 2020 AACI-CRI conference went virtual, but the research community still collaborated and shared best practices on how to keep moving clinical research forward. https://t.co/kJu7kxbwQI

[Forte @forte]

The COVID-19 pandemic forced an era of research quickly adjusting to continue high-quality research. Most adaptations, however, have positioned research to be more patient centric, streamlined, and remote. https://t.co/EApDgFbK4M

[Forte @forte]

Social media connects users worldwide and its role in clinical research has many recruiting and retention benefits. https://t.co/mcISGUGZWC

[Forte @forte]

In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.” Our experts have responded to some of the most popular questions in our most recent blog. https://t.co/0QP0A4kFhQ

[Forte @forte]

With research activities gradually resuming, research teams may be challenged with conducting their trials effectively and efficiently. Here’s how Staff Augmentation can help. https://t.co/rbBbm7izpn

[Forte @forte]

In Advarra's latest virtual symposium, experts discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants. Our experts provided responses to some of the most popular topics in our latest blog: https://t.co/uNdJesyYeb